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OBJECTIVE: To examine determinates of asthma cost in
a large employer population.
METHODS: Data was drawn from the MedStat 
database. Medstat is a claims-based database with over 5
million members. Individuals were identiﬁed as asthmat-
ics based on either a hospitalization, emergency room
(ER) or outpatient visit with a primary diagnosis of
asthma. Final sample size was 107,432.
RESULTS: Overall mean expenditures for inpatient, 
outpatient and emergency room care were $417, the
majority attributable to outpatient care ($270). Both ER
visits (2.6% of the sample) and inpatient stays (2.5%)
were relatively infrequent. But, among ER users, mean ER
expenditures ($438) were greater than total mean expen-
ditures for the typical asthmatic. Similarly, mean hospital
expenditures for those using inpatient services were large
($5,316). ER visits were most likely for those aged 18–34
and became more infrequent with age. Conversely, 
hospital stays were least frequent for those 18–34 and 
otherwise showed no age trend. Although the frequency
of inpatient events didn’t increase with age, the cost was
positively correlated with age, with the lowest mean 
inpatient expenditures for the 18–34 age group ($98) and
the highest for those age 65 and over ($355). Outpatient
costs showed a similar trend, with the highest costs for
those over 65 ($355) and the lowest for the 0–18 age
group ($237). Overall costs in the over 65 age group
($589) were signiﬁcantly greater than the lowest cost
group, ages 18–34 ($375). Mean total costs for women
($446) were higher than for men ($379), largely due to
higher outpatient costs. Women more frequently used
inpatient services (2.7% versus 2.4%), but were less likely
to use the ER (2.5% versus 2.9%).
CONCLUSIONS: Asthma is a high cost chronic illness in
employer populations. Strategies to identify and manage
high cost individuals may lead to cost savings.
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THE COST OF ASTHMA IN CATALONIA:A
DESCRIPTIVE AND MODELLING APPROACH
Rovira J1,Abbas I2, Hermida H2
1The World Bank, Washington, DC, USA; 2SOIKOS, Barcelona,
Spain
OBJECTIVES: To develop a model of the cost of treat-
ment of asthma for planning and evaluation purposes.
METHODS: The model is based on the ﬁve states classi-
ﬁcation of the GIA (Global Initiative on Asthma) A 
preliminary model was designed and validated by a group
of expert clinicians, which deﬁned also the current treat-
ment patterns. On the basis of that information a tem-
plate was designed for the collection of the following
data: visits, in-patient stays, lab tests, drug treatments and
clinical state. Retrospective data were collected for 3 and
5 years from 36 clinical records of 6 outpatient units of
6 Catalan hospitals. The cost at each state as well as the
probabilities of transition between states was derived
from the former data.
RESULTS: The average annual cost at 1997 prices is
US$250. The distribution by resource category is: visits
33.5%, in-patient care 9.3%, lab tests 13.6% and drugs
43.6%. The cost in the ﬁrst year is twice as much as the
average of the following years. There are no signiﬁcant
differences in cost between pediatric and adult patients.
The three years treatment cost does not seem to have
increased over time between the patients starting 
treatment in 1996 and those starting in 1998. The 
initial simulation model gave an annual treatment cost of
US$215, 250 and 285, respectively, for patients being in
states one, two or three at the ﬁrst visit.
CONCLUSIONS: The model reﬂects physicians under-
standing of the disease process and can be easily popu-
lated with data from clinical records. Given the limited
size of the sample, transition probabilities were assumed
to depend only from the previous state, but not from the
state at the ﬁrst visit or from other patient characteristics.
These simplifying assumptions could and should be
relaxed if data from a larger sample were available.
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USE OF AN INTERACTIVE VOICE RESPONSE
SYSTEM (IVRS) FOR LONG-TERM RESOURCE
USE DATA COLLECTION
O’Brien J, Lordan N,Ward A
Caro Research Institute, Concord, MA, USA
OBJECTIVES: Compliance is a concern when trying to
capture resource use (RU) data over a long period. An
IVRS was developed to capture RU data for chronic
obstructive pulmonary disease and to assess the viability
of using a patient-oriented IVRS system for periodic and
long-term RU data collection. This presentation will focus
on results of the second objective.
METHODS: This study was done over 58 weeks in 
parallel with a clinical trial. At the initial study visit, 
subjects were instructed in the use of the IVRS, provided
written instructions and a Health Care Resource Use
Tracking Aid© for each of 14 reporting periods. Subjects
were instructed to record RU daily on the tracking aid
and to report via the IVRS toll-free number each 30 days
during the course of the study. IVRS data were accessed
weekly for data monitoring. Reminders were generated
to patients who did not complete a scheduled report. Two
RU reporting periods extended beyond the last clinical
trial visit. Subjects resided in 23 states.
RESULTS: Males comprised 58% of study subjects; 55%
were greater than 65 years old; and 53% resided in
Southern states. All 381 IVRS users reported resource use
data at least once. The average number of IVRS reports
per subject was 10.5 (sd = 4.5). Of those subjects who
ﬁnished the trial, 89% completed at least 12, and 46%
completed all 14 data reports.
CONCLUSIONS: This study demonstrated that multiple
data reporting via an IVRS can be used successfully for
collecting long-term health care resource use data even
when a substantial portion of the subjects are elderly. The
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IVRS developed for this study provided an optimal
method for collecting detailed analyzable-ready data
without adding additional visits to the trial while 
providing subjects a convenient and user-friendly method
of reporting.
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OBJECTIVES: The purpose of this study was to deter-
mine asthma and allergy disease burden among members
of an employer directed health plans. Speciﬁcally, we were
interested in understanding the impact on total lost days
from work among members who have allergies only,
asthma only, and both allergies and asthma.
METHODS: The study design was descriptive, cross-
sectional, and used self-reported measures. All employees
of participating employer groups were asked to complete
a questionnaire and return it to a third party for pro-
cessing and to assure conﬁdentiality. We measured lost
work hours by asking members about past month absen-
teeism, partial lost days, and lost productivity at work
(presenteeism) on days when the condition was worse
than normal.
RESULTS: Of 13,000 questionnaires sent, we received
4,295 for a 33% response rate. Forty-four percent (n =
1901) of responders reported having allergies only. The
majority (85%) of persons with asthma also reported
having allergies; 303 who had both allergies and asthma
and 58 who had asthma only. Employees with asthma
only reported the fewest average monthly missed hours
from work, 8.5, while employees with allergies missed
15.8 hours. Employees with both allergies and asthma
missed 29.2 hours during the past month. While the
asthma sufferers accounted for fewer lost work hours
compared to the other two groups, their lost hours were
more likely due to time away from work whereas hours
lost among employees with allergies were most likely due
to decreased productivity.
CONCLUSIONS: The signiﬁcant number of lost hours
from work (due to absenteeism, partial missed days, or
lost productivity) resulting from allergies and asthma 
represent a signiﬁcant disease burden for employers and
employees. Estimated annually, employees with asthma,
allergies, and allergies/asthma cost employers $1,938,
$3,602, and $6,658, respectively.
ASTHMA & RESPIRATORY DISEASES/
DISORDERS—Quality of Life Presentations
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CULTURAL ADAPTATION AND VALIDATION OF
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VERSION B (CAQ-B) FOR SINGAPORE
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HRQoL is an important outcome for chronic childhood
diseases such as asthma. However, HRQoL measures are
rarely used in young children in Asia due the difﬁculty 
of obtaining valid, reliable instruments that are develop-
mental and cultural suitable. We adapt the Childhood
Asthma Questionnaires (CAQ) previously used in UK 
and Australia for use in Singapore. These questionnaires
have three versions for different age groups to take into
account the developmental changes: CAQ-A (4–7 years),
CAQ-B (7–11 years) and CAQ-C (11–16 years).
OBJECTIVES: To culturally adapt and validate a disease
speciﬁc HRQoL questionnaire, CAQ-B for childhood
asthma in Singapore.
METHODS: CAQ-B was adapted after pre-testing in
asthmatic children. Changes to the UK and Australia 
versions were made to reﬂect the Singapore school
systems, culture, language and climate. A cross-sectional
validation was conducted. All asthmatic patients attend-
ing the Specialist Respiratory Clinic in KK Women’s and
Children’s Hospital without other co-morbidities that sig-
niﬁcantly affect their HRQoL were invited to participate.
RESULTS: The adapted CAQ-B was validated in 96
patients (40 females and 56 males) with a mean age of
8.7 ± 1.1 years (range: 7–11 years). Most children have
no difﬁculty understanding and completing the question-
naire. The median time to complete a questionnaire was
10 minutes. Internal consistency obtained was slightly
lower than UK and Australia (Cronbach’s alpha =
0.29–0.76). However, this increased to comparable levels
(Cronbach’s alpha = 0.57–0.76) when two items with
confusing phrasing and one item on reading enjoyment
were removed. The Passive Quality of Living Scale
improved from 0.29 to 0.57 when the item regarding
reading was eliminated.
CONCLUSIONS: Asthma Questionnaire (CAQ-B) is a
simple and acceptable HRQoL to children and parents.
The adapted version appeared to be reliable and valid.
However, further investigation is needed to determine the
internal structure of the scales by factor analysis.
